ArticleDiscover oncology2025

Multi-omics analysis identified LGALS1 (Galectin-1) as a novel therapeutic target for clear cell renal cell carcinoma via targeting epithelial or endothelial cells.

Xiangyin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.